Anxiety disorders are a group of conditions characterized by excessive fear, worry, and heightened threat sensitivity that are persistent, disproportionate, and impairing. The seed concept of “Anxiety” is clinically important because it spans normal stress responses as well as maladaptive, pathologic states. Understanding anxiety disorders requires distinguishing adaptive vigilance from disorder-level pathology: in healthy contexts, anxiety rises and falls with situational demands; in anxiety disorders, symptoms persist over time, generalize beyond the original trigger, and produce functional decline in work, school, relationships, and physical health.
The neurobiology of anxiety involves coordinated dysfunction across cortico-striatal-thalamo-cortical circuits, limbic structures, and brainstem arousal systems. Threat processing in the amygdala is often hyper-responsive, while prefrontal regulatory control can be insufficient, leading to impaired inhibition of fear responses. Dysregulation in networks supporting salience detection and cognitive control contributes to attentional bias toward threat and difficulty disengaging from worry. Neurotransmitter systems include serotonergic and noradrenergic pathways that modulate anxiety intensity, and gamma-aminobutyric acid (GABA) mechanisms that influence inhibitory tone. Stress physiology is also central: chronic activation of the hypothalamic–pituitary–adrenal (HPA) axis can perpetuate heightened arousal and somatic symptoms (e.g., muscle tension, gastrointestinal distress, sleep disruption).
Clinically, anxiety disorders are defined not only by subjective distress but also by characteristic symptom clusters and diagnostic criteria. Generalized anxiety disorder (GAD) features excessive anxiety and worry occurring more days than not for at least several months, with difficulty controlling worry and associated symptoms such as restlessness, fatigue, impaired concentration, irritability, muscle tension, and sleep disturbance. Panic disorder involves recurrent unexpected panic attacks—abrupt surges of intense fear peaking within minutes—accompanied by symptoms such as palpitations, sweating, trembling, shortness of breath, chest discomfort, dizziness, paresthesias, and fear of dying or losing control. Social anxiety disorder centers on fear of scrutiny, embarrassment, and negative evaluation, often driving avoidance. Specific phobias involve marked fear of a circumscribed object or situation, while separation anxiety disorder, agoraphobia, and other anxiety-related conditions reflect distinct patterns of fear and avoidance.
Cognitive mechanisms are frequently emphasized in evidence-based models. Cognitive behavioral frameworks propose that worry acts as an overlearned strategy to reduce uncertainty but becomes self-perpetuating: threat predictions generate anxiety, anxiety motivates avoidance or safety behaviors, and these behaviors prevent corrective learning. Intolerance of uncertainty—a tendency to find ambiguous situations unacceptable—predicts persistence and severity, particularly in GAD. Physiological arousal can also create a feedback loop: interoceptive sensations are misinterpreted as dangerous (catastrophic misappraisal), reinforcing panic and phobic avoidance.
Risk factors include genetic vulnerability, temperament traits (e.g., behavioral inhibition), early-life adversity, chronic stress exposure, medical conditions that mimic anxiety (e.g., hyperthyroidism, arrhythmias), and substance or medication effects (including caffeine overuse or withdrawal states). Comorbidity is common: anxiety disorders frequently co-occur with major depressive disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and substance use disorders. This has implications for treatment planning because symptom drivers may be shared while maintaining disorder-specific targets.
Diagnosis is clinical, supported by careful history, mental status examination, and differential evaluation. Clinicians assess symptom duration, severity, triggers, avoidance behaviors, functional impairment, and physical symptom burden. Screening tools (e.g., GAD-7, PHQ-9, and panic-related scales) can quantify severity but do not replace diagnostic judgment. Differential diagnoses include mood disorders, psychotic disorders, trauma-related disorders, and medical etiologies of anxiety-like symptoms. Rule-outs are especially important when anxiety is late-onset, abrupt, or accompanied by prominent autonomic or endocrine signs.
Evidence-based treatments are effective across many anxiety presentations. Psychotherapy is first-line for many patients, particularly cognitive behavioral therapy (CBT). CBT targets maladaptive beliefs, worry processes, and avoidance behaviors using psychoeducation, cognitive restructuring, exposure techniques, and skills training (e.g., interoceptive exposure for panic, graded exposure for phobias, and worry-management strategies for GAD). For GAD, interventions often include behavioral activation elements, problem-solving approaches, and tolerance-building for uncertain outcomes. Exposure is central because it promotes extinction learning and corrects catastrophic expectations.
Pharmacotherapy can be indicated for moderate to severe symptoms, functional impairment, or when psychotherapy access is limited. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used for GAD, social anxiety disorder, and panic disorder. Benzodiazepines may offer short-term relief but carry risks of sedation, cognitive impairment, dependence, and withdrawal; therefore, they are typically reserved for limited-duration bridging strategies or specific circumstances. Buspirone may be used for GAD in some cases. Medication selection should consider comorbidities, past treatment response, pregnancy/breastfeeding status, drug interactions, and patient preferences.
A comprehensive care plan also addresses lifestyle and medical factors that influence anxiety physiology. Sleep regularity, reduction of excessive caffeine or stimulants, management of substance use, and treatment of comorbid depression or pain can improve outcomes. Physical activity can reduce baseline arousal, while mindfulness-based or acceptance-oriented approaches may help patients alter their relationship to intrusive thoughts.
Long-term prognosis is generally favorable with appropriate treatment, but relapse can occur if therapy is incomplete or if avoidance behaviors persist. Ongoing monitoring, maintenance sessions, and relapse-prevention planning are recommended. The core goal is to reduce threat sensitivity, restore cognitive flexibility, and rebuild function through exposure-based learning and targeted cognitive interventions—grounded in rigorous diagnostic assessment.
Source: [ColumbiaUEnergy / BloombergTV interview context]
Center on Global Energy Policy: Oil prices jumped after Israel struck military targets in Iran, raising fresh questions about energy markets and regional stability. On @BloombergTV, CGEP scholar @ProfessorKaren discusses the implications for oil markets. ▶️ Watch the interview:. #breaking
— @ColumbiaUEnergy May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
